These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 14702167

  • 1. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas.
    Kuroda N, Toi M, Yamamoto M, Miyazaki E, Hayashi Y, Hiroi M, Shuin T, Enzan H.
    Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167
    [Abstract] [Full Text] [Related]

  • 2. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
    Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH.
    Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ.
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [Abstract] [Full Text] [Related]

  • 4. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
    Mete O, Kilicaslan I, Gulluoglu MG, Uysal V.
    Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
    [Abstract] [Full Text] [Related]

  • 5. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
    Kuroda N, Guo L, Toi M, Naruse K, Miyazaki E, Hayashi Y, Yoshikawa C, Ashida S, Shuin T, Enzan H.
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
    [Abstract] [Full Text] [Related]

  • 6. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.
    Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B.
    Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081
    [Abstract] [Full Text] [Related]

  • 7. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 8. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B, Ravanshad M, Rahsaz M.
    Indian J Pathol Microbiol; 2008 Jul; 51(2):167-71. PubMed ID: 18603673
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 16. Expression of vitamin D3 receptor in kidney tumors.
    Liu W, Tretiakova M, Kong J, Turkyilmaz M, Li YC, Krausz T.
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [Abstract] [Full Text] [Related]

  • 17. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
    Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SK.
    Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
    [Abstract] [Full Text] [Related]

  • 18. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS.
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [Abstract] [Full Text] [Related]

  • 19. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD, Kim KS, Ryu S, Park Y, Cho NH, Rha SH, Jang JJ, Ro JY, Juhng SW, Choi C.
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC, Chen PC, Ho DM.
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.